The complex interplay of cardiovascular system and cognition: How to predict dementia in the elderly?

International Journal of Cardiology

Volumn 150, Issue 2, 2011, Pages 123-129

  Kerola, Tuomas ^a   Kettunen, Raimo ^a   Nieminen, Tuomo ^a,b  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Alzheimer's disease; Cardiovascular risk; Cognitive dysfunction; Dementia; Elderly; Prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENAZEPRIL; CAPTOPRIL; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; MOEXIPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; TRANDOLAPRIL;

ADIPOSE TISSUE; ALZHEIMER DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; DYSLIPIDEMIA; GERIATRIC PATIENT; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; MULTIINFARCT DEMENTIA; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

AGED; AGING; ANIMALS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEMENTIA; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 79960157577     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.018     Document Type: Review

References (122)

1. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population: prevalence estimates using the 2000 census Arch Neurol 60 2003 1119 1122 (Pubitemid 36975801)
2. C.P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, and M. Ganguli Global prevalence of dementia: a Delphi consensus study Lancet 366 2005 2112 2117 (Pubitemid 41797645)
3. P.J. Whitehouse, C.G. Sciulli, and R.M. Mason Dementia drug development: use of information systems to harmonize global drug development Psychopharmacol Bull 33 1997 129 133 (Pubitemid 27184207)
4. W. Xu, C. Qiu, B. Winblad, and L. Fratiglioni The effect of borderline diabetes on the risk of dementia and Alzheimer's disease Diabetes 56 2007 211 216
5. M. Kivipelto, E.L. Helkala, M.P. Laakso, T. Hanninen, M. Hallikainen, and K. Alhainen Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study Bmj 322 2001 1447 1451 (Pubitemid 32575406)
6. R.P. Kloppenborg, E. van den Berg, L.J. Kappelle, and G.J. Biessels Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review Eur J Pharmacol 585 2008 97 108
7. M.M. Mielke, P.B. Rosenberg, J. Tschanz, L. Cook, C. Corcoran, and K.M. Hayden Vascular factors predict rate of progression in Alzheimer disease Neurology 69 2007 1850 1858 (Pubitemid 350071146)
8. M.C. Morris, P.A. Scherr, L.E. Hebert, R.J. Glynn, D.A. Bennett, and D.A. Evans Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study Arch Neurol 58 2001 1640 1646 (Pubitemid 32963229)
9. T. Erkinjuntti, A. Kurz, S. Gauthier, R. Bullock, S. Lilienfeld, and C.V. Damaraju Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial Lancet 359 2002 1283 1290 (Pubitemid 34310633)
10. A. Viswanathan, W.A. Rocca, and C. Tzourio Vascular risk factors and dementia: how to move forward? Neurology 72 2009 368 374
11. T.F. Hughes, and M. Ganguli Modifiable midlife risk factors for late-life cognitive impairment and dementia Curr Psychiatry Rev 5 2009 73 92
12. A. Ott, R.P. Stolk, A. Hofman, F. van Harskamp, D.E. Grobbee, and M.M. Breteler Association of diabetes mellitus and dementia: the Rotterdam Study Diabetologia 39 1996 1392 1397 (Pubitemid 26356072)
13. General information and national estimates on diabetes in the United States Services USDoHaH 2005 Centers for Disease Control and Prevention.
14. W. Miles, and H. Root Psychologic tests applies to diabetic patients Arch Intern Med 30 1922 767-767
15. G.J. Biessels, S. Staekenborg, E. Brunner, C. Brayne, and P. Scheltens Risk of dementia in diabetes mellitus: a systematic review Lancet Neurol 5 2006 64 74 (Pubitemid 41790697)
16. J.D. Curb, B.L. Rodriguez, R.D. Abbott, H. Petrovitch, G.W. Ross, and K.H. Masaki Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance Neurology 52 1999 971 975 (Pubitemid 29161605)
17. J.A. Luchsinger, M.X. Tang, S. Shea, and R. Mayeux Hyperinsulinemia and risk of Alzheimer disease Neurology 63 2004 1187 1192 (Pubitemid 39350015)
18. E. Ronnemaa, B. Zethelius, J. Sundelof, J. Sundstrom, M. Degerman-Gunnarsson, and C. Berne Impaired insulin secretion increases the risk of Alzheimer disease Neurology 71 2008 1065 1071
19. W. Xu, C. Qiu, M. Gatz, N.L. Pedersen, B. Johansson, and L. Fratiglioni Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study Diabetes 58 2009 71 77
20. J.A. Luchsinger, C. Reitz, B. Patel, M.X. Tang, J.J. Manly, and R. Mayeux Relation of diabetes to mild cognitive impairment Arch Neurol 64 2007 570 575 (Pubitemid 46588347)
21. R.O. Roberts, Y.E. Geda, D.S. Knopman, T.J. Christianson, V.S. Pankratz, and B.F. Boeve Association of duration and severity of diabetes mellitus with mild cognitive impairment Arch Neurol 65 2008 1066 1073
22. R.A. Whitmer, A.J. Karter, K. Yaffe, C.P. Quesenberry Jr., and J.V. Selby Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus Jama 301 2009 1565 1572
23. F.E. de Leeuw, J.C. de Groot, E. Achten, M. Oudkerk, L.M. Ramos, and R. Heijboer Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study J Neurol Neurosurg Psychiatry 70 2001 9 14 (Pubitemid 32096113)
24. R. Ylikoski, A. Ylikoski, T. Erkinjuntti, R. Sulkava, R. Raininko, and R. Tilvis White matter changes in healthy elderly persons correlate with attention and speed of mental processing Arch Neurol 50 1993 818 824 (Pubitemid 23229307)
25. L.H. Kuller, O.L. Lopez, A. Newman, N.J. Beauchamp, G. Burke, and C. Dulberg Risk factors for dementia in the cardiovascular health cognition study Neuroepidemiology 22 2003 13 22 (Pubitemid 36131969)
26. L.C. Silbert, D.B. Howieson, H. Dodge, and J.A. Kaye Cognitive impairment risk: white matter hyperintensity progression matters Neurology 73 2009 120 125
27. Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, et al. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS Study. Neurology 2010;75:160-7.
28. S.M. Manschot, G.J. Biessels, H. de Valk, A. Algra, G.E. Rutten, and J. van der Grond Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes Diabetologia 50 2007 2388 2397 (Pubitemid 47512398)
29. M. Vanhanen, J. Kuusisto, K. Koivisto, L. Mykkanen, E.L. Helkala, and T. Hanninen Type-2 diabetes and cognitive function in a non-demented population Acta Neurol Scand 100 1999 97 101 (Pubitemid 29325315)
30. K. Yaffe, T. Blackwell, A.M. Kanaya, N. Davidowitz, E. Barrett-Connor, and K. Krueger Diabetes, impaired fasting glucose, and development of cognitive impairment in older women Neurology 63 2004 658 663 (Pubitemid 39100821)
31. C.L. Leibson, W.A. Rocca, V.A. Hanson, R. Cha, E. Kokmen, and P.C. O'Brien Risk of dementia among persons with diabetes mellitus: a population-based cohort study Am J Epidemiol 145 1997 301 308 (Pubitemid 27082028)
32. A. Di Carlo, M. Baldereschi, L. Amaducci, S. Maggi, F. Grigoletto, and G. Scarlato Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging J Am Geriatr Soc 48 2000 775 782 (Pubitemid 30457415)
33. E.M. Ebly, D.B. Hogan, and I.M. Parhad Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging Arch Neurol 52 1995 612 619
34. G.J. Biessels Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms Neth J Med 54 1999 35 45
35. S.M. de la Monte, and J.R. Wands Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease J Alzheimers Dis 7 2005 45 61 (Pubitemid 40387184)
36. C.R. Park Cognitive effects of insulin in the central nervous system Neurosci Biobehav Rev 25 2001 311 323 (Pubitemid 32624374)
37. K. Vekrellis, Z. Ye, W.Q. Qiu, D. Walsh, D. Hartley, and V. Chesneau Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme J Neurosci 20 2000 1657 1665 (Pubitemid 30220363)
38. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, and M.P. Frosch Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci USA 100 2003 4162 4167 (Pubitemid 36418174)
39. M.A. Fishel, G.S. Watson, T.J. Montine, Q. Wang, P.S. Green, and J.J. Kulstad Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults Arch Neurol 62 2005 1539 1544 (Pubitemid 41434558)
40. M.N. Haan Therapy insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease Nat Clin Pract Neurol 2 2006 159 166
41. M. Naor, H.J. Steingruber, K. Westhoff, Y. Schottenfeld-Naor, and A.F. Gries Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control J Diab Complications 11 1997 40 46 (Pubitemid 27077768)
42. C.M. Ryan, M.I. Freed, J.A. Rood, A.R. Cobitz, B.R. Waterhouse, and M.W. Strachan Improving metabolic control leads to better working memory in adults with type 2 diabetes Diab Care 29 2006 345 351 (Pubitemid 44106516)
43. A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, and M. Woodward Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572 (Pubitemid 351831357)
44. G.S. Watson, B.A. Cholerton, M.A. Reger, L.D. Baker, S.R. Plymate, and S. Asthana Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study Am J Geriatr Psychiatry 13 2005 950 958 (Pubitemid 46638661)
45. M.E. Risner, A.M. Saunders, J.F. Altman, G.C. Ormandy, S. Craft, and I.M. Foley Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease Pharmacogenomics J 6 2006 246 254 (Pubitemid 44137951)
46. Alderton C., Zvartau-Hind M., Ritchie S., Saunders A., Craft S., and Landreth GL U. Secondary endpoint and responder analyses in a study of rosiglitazone xr in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease International Conference of Alzheimer's Disease 2009 Vienna
47. P.M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P.K. Whelton, and J. He Global burden of hypertension: analysis of worldwide data Lancet 365 2005 217 223 (Pubitemid 40138015)
48. S. Tervo, M. Kivipelto, T. Hanninen, M. Vanhanen, M. Hallikainen, and A. Mannermaa Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects Dement Geriatr Cogn Disord 17 2004 196 203 (Pubitemid 38339747)
49. L.E. Hebert, P.A. Scherr, D.A. Bennett, J.L. Bienias, R.S. Wilson, and M.C. Morris Blood pressure and late-life cognitive function change: a biracial longitudinal population study Neurology 62 2004 2021 2024 (Pubitemid 38738215)
50. T. Yoshitake, Y. Kiyohara, I. Kato, T. Ohmura, H. Iwamoto, and K. Nakayama Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study Neurology 45 1995 1161 1168
51. C. Qiu, B. Winblad, and L. Fratiglioni The age-dependent relation of blood pressure to cognitive function and dementia Lancet Neurol 4 2005 487 499 (Pubitemid 40982459)
52. C. Qiu, B. Winblad, M. Viitanen, and L. Fratiglioni Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study Stroke 34 2003 594 599 (Pubitemid 36307377)
53. J. Verghese, R.B. Lipton, C.B. Hall, G. Kuslansky, and M.J. Katz Low blood pressure and the risk of dementia in very old individuals Neurology 61 2003 1667 1672 (Pubitemid 38020809)
54. Z. Guo, M. Viitanen, L. Fratiglioni, and B. Winblad Low blood pressure and dementia in elderly people: the Kungsholmen project Bmj 312 1996 805 808 (Pubitemid 26099298)
55. A. Ruitenberg, I. Skoog, A. Ott, O. Aevarsson, J.C. Witteman, and B. Lernfelt Blood pressure and risk of dementia: results from the Rotterdam Study and the Gothenburg H-70 Study Dement Geriatr Cogn Disord 12 2001 33 39 (Pubitemid 32008939)
56. C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease Nat Rev Neurosci 5 2004 347 360 (Pubitemid 38568496)
57. T.O. Obisesan Hypertension and cognitive function Clin Geriatr Med 25 2009 259 288
58. O. Hanon, F. Latour, M.L. Seux, H. Lenoir, F. Forette, and A.S. Rigaud Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR) J Nutr Health Aging 9 2005 106 111 (Pubitemid 40478067)
59. G. Zuccala, G. Onder, C. Pedone, L. Carosella, M. Pahor, and R. Bernabei Hypotension and cognitive impairment: selective association in patients with heart failure Neurology 57 2001 1986 1992 (Pubitemid 33126863)
60. M. Feola, G.L. Rosso, M. Peano, M. Agostini, N. Aspromonte, and G. Carena Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure Arch Med Res 38 2007 234 239 (Pubitemid 46080551)
61. J. Gunstad, A. Poppas, S. Smeal, R.H. Paul, D.F. Tate, and A.L. Jefferson Relation of brain natriuretic peptide levels to cognitive dysfunction in adults >55 years of age with cardiovascular disease Am J Cardiol 98 2006 538 540 (Pubitemid 44162885)
62. Kerola T, Nieminen T, Hartikainen S, Sulkava R, Vuolteenaho O, Kettunen R. B-type natriuretic peptide as a predictor of declining cognitive function and dementia-a cohort study of an elderly general population with a 5-year follow-up. Ann Med 2010;42:207-15.
63. Z. Guo, L. Fratiglioni, L. Zhu, J. Fastbom, B. Winblad, and M. Viitanen Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use Arch Neurol 56 1999 991 996 (Pubitemid 29374817)
64. B.A. Veld, A. Ruitenberg, A. Hofman, B.H. Stricker, and M.M. Breteler Antihypertensive drugs and incidence of dementia: the Rotterdam Study Neurobiol Aging 22 2001 407 412 (Pubitemid 32510912)
65. Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. Bmj 2010;340:b5465.
66. K.M. Sink, X. Leng, J. Williamson, S.B. Kritchevsky, K. Yaffe, and L. Kuller Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study Arch Intern Med 169 2009 1195 1202
67. W.B. Applegate, S. Pressel, J. Wittes, J. Luhr, R.B. Shekelle, and G.H. Camel Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program Arch Intern Med 154 1994 2154 2160 (Pubitemid 24317261)
68. F. Forette, M.L. Seux, J.A. Staessen, L. Thijs, W.H. Birkenhager, and M.R. Babarskiene Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial Lancet 352 1998 1347 1351 (Pubitemid 28510916)
69. R. Peters, N. Beckett, F. Forette, J. Tuomilehto, R. Clarke, and C. Ritchie Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial Lancet Neurol 7 2008 683 689
70. I. Skoog, H. Lithell, L. Hansson, D. Elmfeldt, A. Hofman, and B. Olofsson Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE) Am J Hypertens 18 2005 1052 1059 (Pubitemid 41139903)
71. McGuinness B., Todd S., Passmore A.P., and Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia Cochrane Database Syst Rev 4 2009 CD:004034
72. M. Di Bari, M. Pahor, L.V. Franse, R.I. Shorr, J.Y. Wan, and L. Ferrucci Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial Am J Epidemiol 153 2001 72 78 (Pubitemid 32041899)
73. R.A. Whitmer, S. Sidney, J. Selby, S.C. Johnston, and K. Yaffe Midlife cardiovascular risk factors and risk of dementia in late life Neurology 64 2005 277 281
74. M. Kivipelto, E.L. Helkala, M.P. Laakso, T. Hanninen, M. Hallikainen, and K. Alhainen Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease Ann Intern Med 137 2002 149 155 (Pubitemid 34827510)
75. A. Solomon, I. Kareholt, T. Ngandu, B. Winblad, A. Nissinen, and J. Tuomilehto Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study Neurology 68 2007 751 756 (Pubitemid 46667900)
76. N. Scarmeas, Y. Stern, M.X. Tang, R. Mayeux, and J.A. Luchsinger Mediterranean diet and risk for Alzheimer's disease Ann Neurol 59 2006 912 921 (Pubitemid 43830923)
77. M.M. Mielke, P.P. Zandi, M. Sjogren, D. Gustafson, S. Ostling, and B. Steen High total cholesterol levels in late life associated with a reduced risk of dementia Neurology 64 2005 1689 1695 (Pubitemid 40695799)
78. K. Fassbender, M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, and P. Keller Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo Proc Natl Acad Sci USA 98 2001 5856 5861 (Pubitemid 32435732)
79. K. Hoglund, A. Wallin, and K. Blennow Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease Acta Neurol Scand Suppl 185 2006 87 92 (Pubitemid 44015230)
80. S. Bodovitz, and W.L. Klein Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein J Biol Chem 271 1996 4436 4440
81. M. Simons, P. Keller, B. De Strooper, K. Beyreuther, C.G. Dotti, and K. Simons Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons Proc Natl Acad Sci USA 95 1998 6460 6464 (Pubitemid 28249035)
82. T. Nieminen, M. Kahonen, L.E. Viiri, P. Gronroos, and T. Lehtimaki Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease Pharmacogenomics 9 2008 1475 1486
83. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, and S.H. Joo Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472 (Pubitemid 23230526)
84. S. Cosentino, N. Scarmeas, E. Helzner, M.M. Glymour, J. Brandt, and M. Albert APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease Neurology 70 2008 1842 1849 (Pubitemid 351653957)
85. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
86. F.W. Pfrieger Cholesterol homeostasis and function in neurons of the central nervous system Cell Mol Life Sci 60 2003 1158 1171 (Pubitemid 36791918)
87. F. Nourhashemi, and B. Vellas Weight loss as a predictor of dementia and Alzheimer's disease? Expert Rev Neurother 8 2008 691 693 (Pubitemid 351656820)
88. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
89. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, and T.G. Cole The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009 (Pubitemid 26338729)
90. M.D. Haag, A. Hofman, P.J. Koudstaal, B.H. Stricker, and M.M. Breteler Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study J Neurol Neurosurg Psychiatry 80 2009 13 17
91. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 2000 1627 1631
92. Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, et al. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 2010;74:956-64.
93. W.H. Mueller, M.L. Wear, C.L. Hanis, J.B. Emerson, S.A. Barton, and D. Hewett-Emmett Which measure of body fat distribution is best for epidemiologic research? Am J Epidemiol 133 1991 858 869
94. D. Gustafson, E. Rothenberg, K. Blennow, B. Steen, and I. Skoog An 18-year follow-up of overweight and risk of Alzheimer disease Arch Intern Med 163 2003 1524 1528 (Pubitemid 36835095)
95. D.R. Gustafson, K. Backman, M. Waern, S. Ostling, X. Guo, and P. Zandi Adiposity indicators and dementia over 32 years in Sweden Neurology 73 2009 1559 1566
96. M. Kivipelto, T. Ngandu, L. Fratiglioni, M. Viitanen, I. Kareholt, and B. Winblad Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease Arch Neurol 62 2005 1556 1560 (Pubitemid 41434560)
97. R.A. Whitmer, E.P. Gunderson, E. Barrett-Connor, C.P. Quesenberry Jr., and K. Yaffe Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study Bmj 330 2005 1360
98. R.A. Whitmer, D.R. Gustafson, E. Barrett-Connor, M.N. Haan, E.P. Gunderson, and K. Yaffe Central obesity and increased risk of dementia more than three decades later Neurology 71 2008 1057 1064
99. E. Barrett-Connor, S. Edelstein, J. Corey-Bloom, and W. Wiederholt Weight loss precedes dementia in community-dwelling older adults J Nutr Health Aging 2 1998 113 114 (Pubitemid 128695287)
100. D.K. Johnson, C.H. Wilkins, and J.C. Morris Accelerated weight loss may precede diagnosis in Alzheimer disease Arch Neurol 63 2006 1312 1317 (Pubitemid 44379835)
101. R. Stewart, K. Masaki, Q.L. Xue, R. Peila, H. Petrovitch, and L.R. White A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study Arch Neurol 62 2005 55 60 (Pubitemid 40105036)
102. D.S. Knopman, S.D. Edland, R.H. Cha, R.C. Petersen, and W.A. Rocca Incident dementia in women is preceded by weight loss by at least a decade Neurology 69 2007 739 746 (Pubitemid 47300930)
103. F. Nourhashemi, V. Deschamps, S. Larrieu, L. Letenneur, J.F. Dartigues, and P. Barberger-Gateau Body mass index and incidence of dementia: the PAQUID study Neurology 60 2003 117 119 (Pubitemid 36070657)
104. A.R. Atti, K. Palmer, S. Volpato, B. Winblad, D. De Ronchi, and L. Fratiglioni Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project J Am Geriatr Soc 56 2008 111 116
105. J.A. Luchsinger, B. Patel, M.X. Tang, N. Schupf, and R. Mayeux Measures of adiposity and dementia risk in elderly persons Arch Neurol 64 2007 392 398 (Pubitemid 46425695)
106. K. Yaffe, M. Haan, T. Blackwell, E. Cherkasova, R.A. Whitmer, and N. West Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study J Am Geriatr Soc 55 2007 758 762 (Pubitemid 46668964)
107. K. Yaffe, A. Kanaya, K. Lindquist, E.M. Simonsick, T. Harris, and R.I. Shorr The metabolic syndrome, inflammation, and risk of cognitive decline Jama 292 2004 2237 2242 (Pubitemid 39473161)
108. M. Vanhanen, K. Koivisto, L. Moilanen, E.L. Helkala, T. Hanninen, and H. Soininen Association of metabolic syndrome with Alzheimer disease: a population-based study Neurology 67 2006 843 847 (Pubitemid 44394200)
109. E. van den Berg, G.J. Biessels, A.J. de Craen, J. Gussekloo, and R.G. Westendorp The metabolic syndrome is associated with decelerated cognitive decline in the oldest old Neurology 69 2007 979 985 (Pubitemid 47366051)
110. K. Yaffe, A.L. Weston, T. Blackwell, and K.A. Krueger The metabolic syndrome and development of cognitive impairment among older women Arch Neurol 66 2009 324 328
111. Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol 2010;67:428-33.
112. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770 (Pubitemid 28485436)
113. J. Harvey, N. Solovyova, and A. Irving Leptin and its role in hippocampal synaptic plasticity Prog Lipid Res 45 2006 369 378
114. D.C. Fewlass, K. Noboa, F.X. Pi-Sunyer, J.M. Johnston, S.D. Yan, and N. Tezapsidis Obesity-related leptin regulates Alzheimer's Abeta Faseb J 18 2004 1870 1878 (Pubitemid 39602272)
115. W. Lieb, A.S. Beiser, R.S. Vasan, Z.S. Tan, R. Au, and T.B. Harris Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging Jama 302 2009 2565 2572
116. J.S. Meyer, G.M. Rauch, K. Crawford, R.A. Rauch, S. Konno, and H. Akiyama Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia Int J Geriatr Psychiatry 14 1999 1050 1061 (Pubitemid 30066040)
117. K.N. Murray, and N. Abeles Nicotine's effect on neural and cognitive functioning in an aging population Aging Ment Health 6 2002 129 138 (Pubitemid 34587159)
118. J.A. Court, and E.K. Perry Neurotransmitter abnormalities in vascular dementia Int Psychogeriatr 15 Suppl 1 2003 81 87 (Pubitemid 37175172)
119. M.A. Hernan, A. Alonso, and G. Logroscino Cigarette smoking and dementia: potential selection bias in the elderly Epidemiology 19 2008 448 450 (Pubitemid 351543523)
120. Cataldo JK, Prochaska JJ, Glantz SA. Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis; 19:465-480
121. R. Peters, R. Poulter, J. Warner, N. Beckett, L. Burch, and C. Bulpitt Smoking, dementia and cognitive decline in the elderly, a systematic review BMC Geriatr 8 2008 36
122. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150